Tritanium
Device Hips
PDI 07613327039979
General payments
$5,046,212
Research payments
$3,814,594
Through program year 2025, $5,046,212 in general payments and $3,814,594 in research payments were reported against Tritanium (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $178,645 | 380 |
| 2025 | Research | $606,772 | 57 |
| 2024 | General | $483,015 | 623 |
| 2024 | Research | $611,821 | 119 |
| 2023 | General | $913,641 | 1,000 |
| 2023 | Research | $769,235 | 104 |
| 2022 | General | $1,456,823 | 1,438 |
| 2022 | Research | $981,295 | 154 |
| 2021 | General | $2,014,088 | 1,462 |
| 2021 | Research | $845,472 | 139 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,903 general · 573 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.